DIA EUROPE 2019

5 – 7 February 2019

DIA Europe is more than a traditional meeting. It’s a chance to learn, engage, and grow as a healthcare professional alongside thousands of cross-functional collaborative leaders.

Following an unprecedented decade of change for rare diseases and orphan drugs, it’s time to think about the future and make sure the most meaningful times of change are about to start. The session will focus on the much needed stakeholder engagement and explore the regulatory and scientific trends in the field and is the first part of a series on orphan and paediatric drug development in the EU.

Austria Center, Bruno-Kreisky-Platz, Vienna, Austria

Venue

Austria Center
Bruno-Kreisky-Platz 1
1220 Vienna
Austria

The ERNs are co-funded by the
European Union (Health Programme and CEF)

EU Commission


“EURO-NMD is one of the 24 European Reference Networks (ERNs) approved by the ERN Board of Member States. The ERNs are co-funded by the European Union (Health Programme and CEF).
For more information about the ERNs and the EU health strategy,
please visit ec.europa.eu/health/ern